失调的先天免疫信号与RUNX1突变合作,将一种类似MDS的疾病转化为AML
Laura Barreyro1, Avery M Sampson1, Kathleen Hueneman1
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, OH, USA.
iScience
|May 24, 2024
概括
由miR-146a删除驱动的失调的先天免疫信号与突变RUNX1合作,导致骨髓质综合征和急性髓性白血病 (AML). 抑制这种信号抑制了白血病细胞,突出其在AML进展中的作用.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 失调的先天性免疫信号与白血病前的疾病和骨髓性恶性瘤有关.
- 持续的先天性免疫信号在恶性转变中的作用仍然不清楚.
研究的目的:
- 研究细胞内在的先天性免疫信号对髓质性恶性瘤中恶性转变的贡献.
- 确定miR-146a删除和突变RUNX1在白血病发生中的合作作用.
主要方法:
- 使用了具有miR-146a删除 (miR-146aKO) 和突变RUNX1 (RUNX1mut) 的小鼠模型.
- 进行了连续移植试验,以评估血造干细胞和/或原生细胞 (HSPC) 功能和AML进展.
- 研究了一种TRAF6-UBE2N抑制剂在抑制白血病HSPCs中的有效性.
主要成果:
- miR-146aKO与RUNX1mut合作,最初导致骨髓衰竭和骨髓发育综合征 (MDS) 类似的特征.
- miR-146aKO/RUNX1mut HSPCs最终发展为致命的急性髓性白血病 (AML).
- 抑制TRAF6依赖的先天性免疫信号,抑制了白血病的miR-146aKO/RUNX1mut HSPCs.
结论:
- 持续的细胞内在的先天免疫信号,由miR-146a删除加剧,与突变RUNX1合作驱动AML.
- 失调的先天免疫信号需要第二次打击来诱导AML从白血病前细胞的进展.
- 准TRAF6依赖的先天性免疫通路为AML提供了潜在的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Notch Signaling Pathway
4.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


